Kirilys Therapeutics

Operator of a biopharmaceutical company intended for the development of multiple-precision oncology assets. The company is developing a drug that has demonstrated potency, selectivity, and anti-tumor efficacy along with very favorable properties for an oral drug, helping clinicians to improve the treatment of multiple cancers and enhance the lives of patients with chronic kidney disease.

Lightspeed

🏥 Healthcare